ATE460932T1 - Intranasale zusammensetzungen - Google Patents

Intranasale zusammensetzungen

Info

Publication number: ATE460932T1
Authority: AT; Austria
Prior art keywords: compositions; salt; intranasal compositions; derivative; chitosan
Prior art date: 2003-12-05

Application number

AT04798713T

Other languages

English (en)

Inventor

Alan Smith

Peter Watts

Jonathan Castile

Original Assignee

Archimedes Dev Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-12-05

Filing date

2004-11-30

Publication date

2010-04-15

2004-11-30 Application filed by Archimedes Dev Ltd filed Critical Archimedes Dev Ltd

2010-04-15 Application granted granted Critical

2010-04-15 Publication of ATE460932T1 publication Critical patent/ATE460932T1/de

Links

239000000203 mixture Substances 0.000 title abstract 5
150000003839 salts Chemical class 0.000 abstract 3
229920001661 Chitosan Polymers 0.000 abstract 2
206010028813 Nausea Diseases 0.000 abstract 1
206010047700 Vomiting Diseases 0.000 abstract 1
239000007864 aqueous solution Substances 0.000 abstract 1
MFWNKCLOYSRHCJ-BTTYYORXSA-N granisetron Chemical compound C1=CC=C2C(C(=O)N[C@H]3C[C@H]4CCC[C@@H](C3)N4C)=NN(C)C2=C1 MFWNKCLOYSRHCJ-BTTYYORXSA-N 0.000 abstract 1
229960003727 granisetron Drugs 0.000 abstract 1
230000008693 nausea Effects 0.000 abstract 1
230000002265 prevention Effects 0.000 abstract 1
230000008673 vomiting Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Otolaryngology (AREA)
Chemical Kinetics & Catalysis (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

AT04798713T 2003-12-05 2004-11-30 Intranasale zusammensetzungen ATE460932T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0328186.2A GB0328186D0 (en)	2003-12-05	2003-12-05	Intranasal compositions
PCT/GB2004/005043 WO2005056008A1 (en)	2003-12-05	2004-11-30	Intranasal compositions

Publications (1)

Publication Number	Publication Date
ATE460932T1 true ATE460932T1 (de)	2010-04-15

Family

ID=29764615

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT04798713T ATE460932T1 (de)	2003-12-05	2004-11-30	Intranasale zusammensetzungen

Country Status (26)

Country	Link
US (1)	US7947257B2 (de)
EP (1)	EP1696911B1 (de)
JP (1)	JP5103018B2 (de)
KR (1)	KR101194593B1 (de)
CN (2)	CN102389422A (de)
AT (1)	ATE460932T1 (de)
AU (1)	AU2004296586B2 (de)
BR (1)	BRPI0417350A2 (de)
CA (1)	CA2548559C (de)
CY (1)	CY1110664T1 (de)
DE (1)	DE602004026107D1 (de)
DK (1)	DK1696911T3 (de)
ES (1)	ES2357607T3 (de)
GB (1)	GB0328186D0 (de)
HR (1)	HRP20100343T1 (de)
IL (1)	IL176132A (de)
ME (1)	ME01070B (de)
MX (1)	MXPA06006239A (de)
NO (1)	NO335348B1 (de)
NZ (1)	NZ547848A (de)
PL (1)	PL1696911T3 (de)
PT (1)	PT1696911E (de)
RS (1)	RS51251B (de)
SI (1)	SI1696911T1 (de)
WO (1)	WO2005056008A1 (de)
ZA (1)	ZA200604553B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7638138B2 (en)	2003-02-21	2009-12-29	Translational Research, Ltd.	Compositions for nasal administration of pharmaceuticals
USRE45404E1 (en)	2003-03-27	2015-03-03	Shin Nippon Biomedical Laboratories, Ltd.	Powder medicine applicator for nasal cavity
WO2006016530A1 (ja)	2004-08-10	2006-02-16	Translational Research, Ltd.	速効性でかつ高い吸収性を可能とする経鼻投与用組成物
US7868016B2 (en) *	2005-07-13	2011-01-11	Baxter International Inc.	Pharmaceutical formulations of endo-N-(9-methyl-9-azabicyclo[3,3.1]non-3-yl)-1-methyl-1H-indazole-3-carboxamide hydrochloride
DE112005003703T5 (de) *	2005-09-23	2008-07-10	Amphenol Phoenix Co., Ltd., Hwaseong	Öffnungs- und Schließvorrichtung in Gleitbauweise zur Verwendung in Mobiltelefonen
ATE544444T1 (de) *	2005-10-11	2012-02-15	Yissum Res Dev Co	Zusammensetzungen für die nasale abgabe
ES2652415T3 (es)	2006-12-26	2018-02-02	Shin Nippon Biomedical Laboratories, Ltd.	Preparación para aplicación transnasal
US9101539B2 (en)	2009-05-15	2015-08-11	Shin Nippon Biomedical Laboratories, Ltd.	Intranasal pharmaceutical compositions with improved pharmacokinetics
US8827946B2 (en)	2009-07-31	2014-09-09	Shin Nippon Biomedical Laboratories, Ltd.	Intranasal granisetron and nasal applicator
KR101368587B1 (ko) *	2010-12-27	2014-03-05	주식회사 삼양바이오팜	오심 또는 구토 방지용 조성물
JP6081102B2 (ja) *	2012-08-10	2017-02-15	テルモ株式会社	安定なグラニセトロン含有水性製剤
AU2015390261A1 (en)	2015-04-08	2017-11-30	Maxinase Life Sciences Limited	Bioadhesive compositions for intranasal administration of granistron
CA3011015C (en) *	2016-01-12	2024-04-16	Nortic Holdings Inc.	Betamethasone oral spray formulation and method of use to treat ataxia
US11744967B2 (en)	2017-09-26	2023-09-05	Shin Nippon Biomedical Laboratories, Ltd.	Intranasal delivery devices
GB202301322D0 (en) *	2023-01-30	2023-03-15	Therakind Ltd	Antiemetic pharmaceutical compositions for nasal delivery

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2004270A1 (en)	1988-12-29	1990-06-29	William R. Michael	Perfume microcapsules for use in granular detergent compositions
CA2042529C (en)	1990-08-10	2002-07-30	Chokyun Rha	Polysaccharide article and uses therefor
US5929059A (en) *	1991-01-19	1999-07-27	Smithkline Beecham P.L.C.	Pharmaceutical compositions containing granisetron and dexamethasone
GB9305593D0 (en) *	1993-03-18	1993-05-05	Smithkline Beecham Plc	Pharmaceuticals
US5897858A (en) *	1994-02-03	1999-04-27	Schering-Plough Healthcare Products, Inc.	Nasal spray compositions exhibiting increased retention in the nasal cavity
GB9406171D0 (en) *	1994-03-29	1994-05-18	Electrosols Ltd	Dispensing device
HRP950149A2 (en)	1994-04-13	1997-06-30	Janssen Pharmaceutica Nv	Intranasal antimigrene composition
GB9414966D0 (en)	1994-07-26	1994-09-14	Danbiosyst Uk	Pharmaceutical compositions for the nasal administration of antiviral agents
GB9700624D0 (en)	1997-01-14	1997-03-05	Danbiosyst Uk	Drug delivery composition
GB9713980D0 (en)	1997-07-03	1997-09-10	Danbiosyst Uk	New conjugates
US20020132803A1 (en) *	2001-01-05	2002-09-19	Mahendra Dedhiya	Fluticasone suspension formulation, spray pattern method, and nasal spray apparatus
JP2002255795A (ja) *	2001-02-26	2002-09-11	Teijin Ltd	経鼻投与用組成物
US20030044356A1 (en) *	2001-04-20	2003-03-06	Jin Auh	Composition for nasal solution sprays having effective component of 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carbazol-4-one)
US7666876B2 (en) *	2002-03-19	2010-02-23	Vernalis (R&D) Limited	Buprenorphine formulations for intranasal delivery
CN1332664C (zh) *	2002-04-26	2007-08-22	中国人民解放军军事医学科学院毒物药物研究所	鼻粉剂
CN1289085C (zh) *	2002-04-26	2006-12-13	中国人民解放军军事医学科学院毒物药物研究所	鼻腔喷雾剂
GB0329918D0 (en)	2003-12-24	2004-01-28	West Pharm Serv Drug Res Ltd	Intranasal compositions

2003
- 2003-12-05 GB GBGB0328186.2A patent/GB0328186D0/en not_active Ceased
2004
- 2004-11-30 CA CA2548559A patent/CA2548559C/en not_active Expired - Fee Related
- 2004-11-30 PL PL04798713T patent/PL1696911T3/pl unknown
- 2004-11-30 PT PT04798713T patent/PT1696911E/pt unknown
- 2004-11-30 CN CN2011102427243A patent/CN102389422A/zh active Pending
- 2004-11-30 HR HR20100343T patent/HRP20100343T1/hr unknown
- 2004-11-30 EP EP04798713A patent/EP1696911B1/de not_active Expired - Lifetime
- 2004-11-30 DE DE602004026107T patent/DE602004026107D1/de not_active Expired - Lifetime
- 2004-11-30 AT AT04798713T patent/ATE460932T1/de active
- 2004-11-30 ES ES04798713T patent/ES2357607T3/es not_active Expired - Lifetime
- 2004-11-30 MX MXPA06006239A patent/MXPA06006239A/es active IP Right Grant
- 2004-11-30 KR KR1020067013467A patent/KR101194593B1/ko not_active Expired - Fee Related
- 2004-11-30 AU AU2004296586A patent/AU2004296586B2/en not_active Ceased
- 2004-11-30 ME MEP-2010-80A patent/ME01070B/me unknown
- 2004-11-30 RS RSP-2010/0211A patent/RS51251B/sr unknown
- 2004-11-30 DK DK04798713.6T patent/DK1696911T3/da active
- 2004-11-30 BR BRPI0417350-3A patent/BRPI0417350A2/pt not_active Application Discontinuation
- 2004-11-30 CN CNA2004800398583A patent/CN1901905A/zh active Pending
- 2004-11-30 NZ NZ547848A patent/NZ547848A/en not_active IP Right Cessation
- 2004-11-30 SI SI200431395T patent/SI1696911T1/sl unknown
- 2004-11-30 JP JP2006542003A patent/JP5103018B2/ja not_active Expired - Fee Related
- 2004-11-30 WO PCT/GB2004/005043 patent/WO2005056008A1/en not_active Ceased
- 2004-12-03 US US11/004,556 patent/US7947257B2/en not_active Expired - Fee Related
2006
- 2006-06-02 NO NO20062548A patent/NO335348B1/no not_active IP Right Cessation
- 2006-06-02 ZA ZA200604553A patent/ZA200604553B/xx unknown
- 2006-06-05 IL IL176132A patent/IL176132A/en not_active IP Right Cessation
2010
- 2010-06-11 CY CY20101100528T patent/CY1110664T1/el unknown

Also Published As

Publication number	Publication date
DK1696911T3 (da)	2010-06-28
AU2004296586A2 (en)	2005-06-23
JP2007513129A (ja)	2007-05-24
NO335348B1 (no)	2014-11-24
KR101194593B1 (ko)	2012-10-25
RS51251B (sr)	2010-12-31
ZA200604553B (en)	2009-09-30
HRP20100343T1 (hr)	2010-11-30
EP1696911B1 (de)	2010-03-17
EP1696911A1 (de)	2006-09-06
SI1696911T1 (sl)	2010-06-30
PT1696911E (pt)	2010-04-29
AU2004296586A1 (en)	2005-06-23
PL1696911T3 (pl)	2010-08-31
DE602004026107D1 (de)	2010-04-29
IL176132A0 (en)	2006-10-05
NO20062548L (no)	2006-08-15
NZ547848A (en)	2009-04-30
BRPI0417350A2 (pt)	2009-03-10
CN1901905A (zh)	2007-01-24
WO2005056008A1 (en)	2005-06-23
CA2548559A1 (en)	2005-06-23
KR20060126532A (ko)	2006-12-07
IL176132A (en)	2010-12-30
CA2548559C (en)	2013-09-03
ME01070B (me)	2012-10-20
US20050142073A1 (en)	2005-06-30
GB0328186D0 (en)	2004-01-07
CN102389422A (zh)	2012-03-28
CY1110664T1 (el)	2015-06-10
AU2004296586B2 (en)	2010-08-12
US7947257B2 (en)	2011-05-24
JP5103018B2 (ja)	2012-12-19
ES2357607T3 (es)	2011-04-28
MXPA06006239A (es)	2006-08-23

Legal Events

Date

Code

Title

Description

2010-08-15

UEP

Publication of translation of european patent specification

Ref document number: 1696911

Country of ref document: EP

Publication	Publication Date	Title
CY1110664T1 (el)	2015-06-10	Ενδορινικες συνθεσετς
MXPA06000675A (es)	2006-04-19	Derivado de quinolona o sal del mismo.
NO20054244D0 (no)	2005-09-13	Nitrogeninneholdende heterocykliske derivater og legemidler inneholdende de samme som den aktive bestanddel
NO2017047I1 (no)	2017-09-08	Tofacitinib, evt. i form av et farmasøytisk akseptabelt salt, inkludert citratsalt
IL175953A (en)	2015-09-24	Derivatives of 3-Cycloalkylaminopyrrolidine, their Pharmaceutical Salts and Preparations Containing Them
WO2007087431A3 (en)	2008-09-25	Sublingual fentanyl spray
NO20043702L (no)	2004-12-03	8-azaprostaglandinderivatforbindelser og legemidler inneholdende forbindelsene som den aktive bestanddel
WO2009017837A3 (en)	2009-04-30	Sublingual fentanyl spray
TW200642689A (en)	2006-12-16	Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient
DK1498411T3 (da)	2013-04-15	Diketohydrazinderivatforbindelser og medikamenter indeholdende forbindelserne som den aktive bestanddel
NO20061840L (no)	2006-06-26	Legemiddelbelegg som tilveiebringer hoy legemiddeltilsetning og fremgangsmater for a tilveiebringe samme
EP4424375A3 (de)	2024-11-20	Antineoplastische kombinationen aus neratinib und capecitabin
DK1557415T3 (da)	2012-09-17	Heterocykliske forbindelser og antitumorlægemidler indeholdende samme som den aktive ingrediens
UA90518C2 (ru)	2010-05-11	Фармацевтическая композиция в форме таблетки, которая имеет улучшеное всасывание при трансбукальном введение, которая содержит наркотический активный ингредиент и амин
TW200716628A (en)	2007-05-01	Novel compounds
TW200502231A (en)	2005-01-16	Prodrugs of proton pump inhibitors
SE0101932D0 (sv)	2001-05-31	Pharmaceutical combinations
DK1121127T3 (da)	2005-05-02	Orale farmaceutiske sammensætninger, som indeholder buprenorphin
PE20030061A1 (es)	2003-02-08	1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4
WO2005032490A3 (en)	2005-07-28	Cyclic diamines and derivatives as factor xa inhibitors
NO20074167L (no)	2007-08-13	Peptidiske forbindelser
EE200300129A (et)	2003-06-16	Distamütsiini alfa-halogenoakrüloüülderivaadi kasutamine
MXPA04003851A (es)	2004-07-08	Antipruriticos.
TW200733963A (en)	2007-09-16	Cough inhibitor
WO2005023188A3 (en)	2005-08-11	Compounds and methods